A recombinant vaccine based on domain II of Plasmodium vivax Apical Membrane Antigen 1 induces high antibody titres in mice

Vaccine

Volumn 28, Issue 38, 2010, Pages 6183-6190

  Gentil, Fernanda ^a   Bargieri, Daniel Y ^b   Leite, Juliana A ^c   Françoso, Kátia S ^a   Patricio, Mariana B M ^a   Espíndola, Noeli M ^a   Vaz, Adelaide J ^a   Palatnik de Sousa, Clarisa B ^d   Rodrigues, Mauricio M ^b   Costa, Fabio T M ^c   Soares, Irene S ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

^b FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

^c UNIVERSITY OF CAMPINAS   (Brazil)

^d FEDERAL UNIVERSITY OF RIO DE JANEIRO   (Brazil)

Author keywords

Malaria; Plasmodium vivax; Recombinant vaccine

Indexed keywords

ADJUVANT; ALUMINUM HYDROXIDE; APICAL MEMBRANE ANTIGEN 1; FREUND ADJUVANT; IMMUNOGLOBULIN G ANTIBODY; OLIGODEOXYNUCLEOTIDE; PLASMODIUM VIVAX APICAL MEMBRANE ANTIGEN 1 DOMAIN II VACCINE; QUIL A; RECOMBINANT VACCINE; SAPONIN; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBODY RESPONSE; ANTIBODY TITER; ANTIGEN EXPRESSION; ARTICLE; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; IMMUNOBLOTTING; IMMUNOFLUORESCENCE; IMMUNOFLUORESCENCE TEST; IMMUNOGENICITY; MALARIA; MEROZOITE; MOUSE; NONHUMAN; PLASMODIUM VIVAX; POLYACRYLAMIDE GEL ELECTROPHORESIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PURIFICATION; REVERSED PHASE HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; VACCINATION; WESTERN BLOTTING;

EID: 77955654465     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vaccine.2010.07.017     Document Type: Article

References (51)

1. Price R.N., Tjitra E., Guerra C.A., Yeung S., White N.J., Anstey N.M. Vivax malaria: neglected and not benign. Am J Trop Med Hyg 2007, 77(6 Suppl.):79-87.
2. Tan L.K., Yacoub S., Scott S., Bhagani S., Jacobs M. Acute lung injury and other serious complications of Plasmodium vivax malaria. Lancet Infect Dis 2008, 8(7):449-454.
3. Anstey N.M., Russell B., Yeo T.W., Price R.N. The pathophysiology of vivax malaria. Trends Parasitol 2009, 25(5):220-227.
4. Baird J.K. Neglect of Plasmodium vivax malaria. Trends Parasitol 2007, 23(11):533-539.
5. Greenwood B.M. Control to elimination: implications for malaria research. Trends Parasitol 2008, 24(10):449-454.
6. Polley S.D., McRobert L., Sutherland C.J. Vaccination for vivax malaria: targeting the invaders. Trends Parasitol 2004, 20(3):99-102.
7. Chitnis C.E., Sharma A. Targeting the Plasmodium vivax Duffy-binding protein. Trends Parasitol 2008, 24(1):29-34.
8. Herrera S., Corradin G., Arevalo-Herrera M. An update on the search for a Plasmodium vivax vaccine. Trends Parasitol 2007, 23(3):122-128.
9. Remarque E.J., Faber B.W., Kocken C.H., Thomas A.W. Apical membrane antigen 1: a malaria vaccine candidate in review. Trends Parasitol 2008, 24(2):74-84.
10. Galinski M.R., Barnwell J.W. Plasmodium vivax: who cares?. Malar J 2008, 7 Suppl. 1:S9.
11. Hodder A.N., Crewther P.E., Matthew M.L., Reid G.E., Moritz R.L., Simpson R.J., et al. The disulfide bond structure of Plasmodium apical membrane antigen-1. J Biol Chem 1996, 271(46):29446-29452.
12. Gaffar F.R., Yatsuda A.P., Franssen F.F., de Vries E. Erythrocyte invasion by Babesia bovis merozoites is inhibited by polyclonal antisera directed against peptides derived from a homologue of Plasmodium falciparum apical membrane antigen 1. Infect Immun 2004, 72(5):2947-2955.
13. Donahue C.G., Carruthers V.B., Gilk S.D., Ward G.E. The Toxoplasma homolog of Plasmodium apical membrane antige-1 (AMA-1) is a microneme protein secreted in response to elevated intracellular calcium levels. Mol Biochem Parasitol 2000, 111(1):15-30.
14. Narum D.L., Thomas A.W. Differential localization of full-length and processed forms of PF83/AMA-1 an apical membrane antigen of Plasmodium falciparum merozoites. Mol Biochem Parasitol 1994, 67(1):59-68.
15. Pizarro J.C., Vulliez-Le Normand B., Chesne-Seck M.L., Collins C.R., Withers-Martinez C., Hackett F., et al. Crystal structure of the malaria vaccine candidate apical membrane antigen 1. Science 2005, 308(5720):408-411.
16. Kocken C.H., Dubbeld M.A., Van Der Wel A., Pronk J.T., Waters A.P., Langermans J.A., et al. High-level expression of Plasmodium vivax apical membrane antigen 1 (AMA-1) in Pichia pastoris: strong immunogenicity in Macaca mulatta immunized with P. vivax AMA-1 and adjuvant SBAS2. Infect Immun 1999, 67(1):43-49.
17. Thomas A.W., Deans J.A., Mitchell G.H., Alderson T., Cohen S. The Fab fragments of monoclonal IgG to a merozoite surface antigen inhibit Plasmodium knowlesi invasion of erythrocytes. Mol Biochem Parasitol 1984, 13(2):187-199.
18. Li F., Dluzewski A., Coley A.M., Thomas A., Tilley L., Anders R.F., et al. Phage-displayed peptides bind to the malarial protein apical membrane antigen-1 and inhibit the merozoite invasion of host erythrocytes. J Biol Chem 2002, 277(52):50303-50310.
19. Mitchell G.H., Thomas A.W., Margos G., Dluzewski A.R., Bannister L.H. Apical membrane antigen 1, a major malaria vaccine candidate, mediates the close attachment of invasive merozoites to host red blood cells. Infect Immun 2004, 72(1):154-158.
20. Silvie O., Franetich J.F., Charrin S., Mueller M.S., Siau A., Bodescot M., et al. A role for apical membrane antigen 1 during invasion of hepatocytes by Plasmodium falciparum sporozoites. J Biol Chem 2004, 279(10):9490-9496.
21. Triglia T., Healer J., Caruana S.R., Hodder A.N., Anders R.F., Crabb B.S., et al. Apical membrane antigen 1 plays a central role in erythrocyte invasion by Plasmodium species. Mol Microbiol 2000, 38(4):706-718.
22. Hehl A.B., Lekutis C., Grigg M.E., Bradley P.J., Dubremetz J.F., Ortega-Barria E., et al. Toxoplasma gondii homologue of Plasmodium apical membrane antigen 1 is involved in invasion of host cells. Infect Immun 2000, 68(12):7078-7086.
23. Kocken C.H., van der Wel A.M., Dubbeld M.A., Narum D.L., van de Rijke F.M., van Gemert G.J., et al. Precise timing of expression of a Plasmodium falciparum-derived transgene in Plasmodium berghei is a critical determinant of subsequent subcellular localization. J Biol Chem 1998, 273(24):15119-15124.
24. Collins C.R., Withers-Martinez C., Bentley G.A., Batchelor A.H., Thomas A.W., Blackman M.J. Fine mapping of an epitope recognized by an invasion-inhibitory monoclonal antibody on the malaria vaccine candidate apical membrane antigen 1. J Biol Chem 2007, 282(10):7431-7441.
25. Collins C.R., Withers-Martinez C., Hackett F., Blackman M.J. An inhibitory antibody blocks interactions between components of the malarial invasion machinery. PLoS Pathog 2009, 5(1):e1000273.
26. Rodrigues M.H.C., Rodrigues K.M., Oliveira T.R., Comodo A.N., Rodrigues M.M., Kocken C.H., et al. Antibody response of naturally infected individuals to recombinant Plasmodium vivax apical membrane antigen-1. Int J Parasitol 2005, 35(2):185-192.
27. Morais C.G., Soares I.S., Carvalho L.H., Fontes C.J., Krettli A.U., Braga E.M. Antibodies to Plasmodium vivax apical membrane antigen 1: persistence and correlation with malaria transmission intensity. Am J Trop Med Hyg 2006, 75(4):582-587.
28. Barbedo M.B., Ricci R., Jimenez M.C., Cunha M.G., Yazdani S.S., Chitnis C.E., et al. Comparative recognition by human IgG antibodies of recombinant proteins representing three asexual erythrocytic stage vaccine candidates of Plasmodium vivax. Mem Inst Oswaldo Cruz 2007, 102(3):335-339.
29. Wickramarachchi T., Premaratne P.H., Perera K.L., Bandara S., Kocken C.H., Thomas A.W., et al. Natural Human Antibody Responses to Plasmodium vivax apical membrane antigen 1 under low transmission and unstable malaria conditions in Sri Lanka. Infect Immun 2006, 74(1):798-801.
30. Polley S.D., Mwangi T., Kocken C.H., Thomas A.W., Dutta S., Lanar D.E., et al. Human antibodies to recombinant protein constructs of Plasmodium falciparum Apical Membrane Antigen 1 (AMA1) and their associations with protection from malaria. Vaccine 2004, 23(5):718-728.
31. Mufalo B.C., Gentil F., Bargieri D.Y., Costa F.T., Rodrigues M.M., Soares I.S. Plasmodium vivax apical membrane antigen-1: comparative recognition of different domains by antibodies induced during natural human infection. Microbes Infect 2008, 10(12-13):1266-1273.
32. Oliveira-Freitas E., Casas C.P., Borja-Cabrera G.P., Santos F.N., Nico D., Souza L.O.P., et al. Acylated and deacylated saponins of Quillaja saponaria mixture as adjuvants for the FML-vaccine against visceral leishmaniasis. Vaccine 2006, 24:3909-3920.
33. Bargieri D.Y., Rosa D.S., Braga C.J., Carvalho B.O., Costa F.T., Espindola N.M., et al. New malaria vaccine candidates based on the Plasmodium vivax Merozoite Surface Protein-1 and the TLR-5 agonist Salmonella Typhimurium FliC flagellin. Vaccine 2008, 26(48):6132-6142.
34. Bargieri D.Y., Leite J.A., Lopes S.C.P., Sbrogio-Almeida E., Braga C.J., Ferreira L.C., et al. Immunogenic properties of a recombinant fusion protein containing the C-terminal 19 kDa of Plasmodium falciparum Merozoite Surface Protein-1 and the innate immunity agonist FliC flagellin of Salmonella Typhimurium. Vaccine 2010, 28(16):2818-2826.
35. Crewther P.E., Matthew M.L., Flegg R.H., Anders R.F. Protective immune responses to apical membrane antigen 1 of Plasmodium chabaudi involve recognition of strain-specific epitopes. Infect Immun 1996, 64(8):3310-3317.
36. Anders R.F., Crewther P.E., Edwards S., Margetts M., Matthew M.L., Pollock B., et al. Immunisation with recombinant AMA-1 protects mice against infection with Plasmodium chabaudi. Vaccine 1998, 16(2-3):240-247.
37. Narum D.L., Ogun S.A., Thomas A.W., Holder A.A. Immunization with parasite-derived apical membrane antigen 1 or passive immunization with a specific monoclonal antibody protects BALB/c mice against lethal Plasmodium yoelii yoelii YM blood-stage infection. Infect Immun 2000, 68(5):2899-2906.
38. Hodder A.N., Crewther P.E., Anders R.F. Specificity of the protective antibody response to apical membrane antigen 1. Infect Immun 2001, 69(5):3286-3294.
39. Kocken C.H., Withers-Martinez C., Dubbeld M.A., van der Wel A., Hackett F., Valderrama A., et al. High-level expression of the malaria blood-stage vaccine candidate Plasmodium falciparum apical membrane antigen 1 and induction of antibodies that inhibit erythrocyte invasion. Infect Immun 2002, 70(8):4471-4476.
40. Dutta S., Lalitha P.V., Ware L.A., Barbosa A., Moch J.K., Vassell M.A., et al. Purification, characterization, and immunogenicity of the refolded ectodomain of the Plasmodium falciparum apical membrane antigen 1 expressed in Escherichia coli. Infect Immun 2002, 70(6):3101-3110.
41. Kennedy M.C., Wang J., Zhang Y., Miles A.P., Chitsaz F., Saul A., et al. In vitro studies with recombinant Plasmodium falciparum apical membrane antigen 1 (AMA1): production and activity of an AMA1 vaccine and generation of a multiallelic response. Infect Immun 2002, 70(12):6948-6960.
42. Lalitha P.V., Ware L.A., Barbosa A., Dutta S., Moch J.K., Haynes J.D., et al. Production of the subdomains of the Plasmodium falciparum apical membrane antigen 1 ectodomain and analysis of the immune response. Infect Immun 2004, 72(8):4464-4470.
43. Lalitha P.V., Biswas S., Pillai C.R., Saxena R.K. Immunogenicity of a recombinant malaria vaccine candidate, domain I+II of AMA-1 ectodomain, from Indian P. falciparum alleles. Vaccine 2008, 26(35):4526-4535.
44. Dutta S., Sullivan J.S., Grady K.K., Haynes J.D., Komisar J., Batchelor A.H., et al. High antibody titer against apical membrane antige-1 is required to protect against malaria in the Aotus model. PLoS One 2009, 4(12):e8138.
45. Rogers W.O., Gowda K., Hoffman S.L. Construction and immunogenicity of DNA vaccine plasmids encoding four Plasmodium vivax candidate vaccine antigens. Vaccine 1999, 17(23-24):3136-3144.
46. Gunasekera A.M., Wickramarachchi T., Neafsey D.E., Ganguli I., Perera L., Premaratne P.H., et al. Genetic diversity and selection at the Plasmodium vivax apical membrane antigen-1 (PvAMA-1) locus in a Sri Lankan population. Mol Biol Evol 2007, 24(4):939-947.
47. Figtree M., Pasay C.J., Slade R., Cheng Q., Cloonan N., Walker J., et al. Plasmodium vivax synonymous substitution frequencies, evolution and population structure deduced from diversity in AMA-1 and MSP-1 genes. Mol Biochem Parasitol 2000, 108(1):53-66.
48. Grynberg P., Fontes C.J., Hughes A.L., Braga E.M. Polymorphism at the apical membrane antigen I locus reflects world population history of Plasmodium vivax. BMC Evol Biol 2008, 8:123.
49. Rajesh V., Elamaran M., Vidya S., Gowrishankar M., Kochar D., Das A. Plasmodium vivax: genetic diversity of the apical membrane antigen-1 (AMA-1) in isolates from India. Exp Parasitol 2007, 116(3):252-256.
50. Putaporntip C., Jongwutiwes S., Grynberg P., Cui L., Hughes A.L. Nucleotide sequence polymorphism at the apical membrane antigen-1 locus reveals population history of Plasmodium vivax in Thailand. Infect Genet Evol 2009, 9(6):1295-1300.
51. Chesne-Seck M.L., Pizarro J.C., Vulliez-Le Normand B., Collins C.R., Blackman M.J., Faber B.W., et al. Structural comparison of apical membrane antigen 1 orthologues and paralogues in apicomplexan parasites. Mol Biochem Parasitol 2005, 144(1):55-67.